Suchergebnisse - "Caimi, Paolo F"

PubPharm (115)

1

Allogeneic CAR T Cells : Complex Cellular Therapy Designs Test the Limits of Our Preclinical Models

enthalten in: Cancer immunology research | 2024

von Caimi, P. | Melenhorst, J.

2

Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma : long-term efficacy and safety from the phase II LOTIS-2 study

enthalten in: Haematologica | 2024

von Caimi, P. | Ai, W. | Alderuccio, J. | +13

3

A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia

enthalten in: Blood advances | 2024

von Metheny, L. | Sobecks, R. | Cho, C. | +18

4

BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation

enthalten in: American journal of hematology | 2024

von Stuver, R. | Mian, A. | Brown, S. | +16

5

In relapsed or refractory diffuse large B-cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine

enthalten in: EJHaem | 2024

von Caimi, P. | Hamadani, M. | Carlo-Stella, C. | +10

6

A paradox of choice : Sequencing therapy in relapsed/refractory diffuse large B-cell lymphoma

enthalten in: Blood reviews | 2024

von Brooks, T. | Caimi, P.

7

Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial

enthalten in: Blood advances | 2024

von Hamadani, M. | Spira, A. | Zhou, X. | +16

8

PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Alderuccio, J. | Reis, I. | Hamadani, M. | +18

9

In relapsed or refractory diffuse large B‐cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine

enthalten in: eJHaem | 2024

von Caimi, P. | Hamadani, M. | Carlo‐Stella, C. | +10

10

Tafasitamab and lenalidomide in large B-cell lymphoma : real-world outcomes in a multicenter retrospective study

enthalten in: Blood | 2023

von Qualls, D. | Lambert, N. | Caimi, P. | +21

CommentIn: Blood. 2023 Dec 28;142(26):2232-2234. - PMID 38153771

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]